UK says AstraZeneca Shot is safe even after 7 blood clot deaths

Sign up here for our daily coronavirus newsletter on what you need to know and subscribe to our Covid-19 podcast for the latest news and analysis.

The UK confirmed that seven people had died from rare clots after receiving it AstraZeneca Plc’s Covid-19 vaccine and Australia are also investigating a case of coagulation, raising questions about the safety of the widely used coronavirus trait.

Medicines and the United Kingdom Health care Products Agency Agency said on Saturday that of 30 cases of clotting and low blood platelets identified in people in the UK who had been shot by March 24, seven had died. More than 18 million doses have been administered in the country and the regulator insists the shooting is safe.

“The benefits of the Covid-19 AstraZeneca vaccine to prevent Covid-19 infection and its complications continue to outweigh the risks and the public should continue to get the vaccine when invited to do so,” June Raine said Saturday , the CEO of MHRA. an email statement.

Australia said yes on Saturday cooperating with UK and European Union regulators after identifying a case of blood clotting on April 2 in someone who had been shot by AstraZeneca.

The latest revelation is likely to add to the growing concern over the AstraZeneca vaccine, which is the backbone of the success of the UK inoculation campaign. Many countries around the world relied on AstraZeneca to boost their vaccination programs and now some are reconsidering despite rising levels of Covid cases.

The Netherlands joined on Friday Germany suspended the use of the vaccine in people under 60 years of age. Norway and Denmark extended suspensions over the use of the shot, which has also been the subject of a supply dispute between the EU, the UK and others.

Friday in South Africa concluded the sale of one million shots to other countries after finding that they had little impact on a variant first identified in the country last year.

The UK continues to move forward with its vaccine program, which has delivered a first vaccine to more than 60% of all adults. Prime Minister Boris Johnson has pledged to offer a first shot to all adults by the end of July, with vaccination against Astra key to achieving that goal.

Blood clots, anaphylaxis, and other vaccine fears: rapid intake

With the new reports on the clotting condition, the incidence rate after the shooting of AstraZeneca in the UK is about 1 in 600,000. The same reactions to the vaccine were not reported Pfizer Inc. i BioNTech SE, which is also used in Britain.

Earlier this week, the EU drug regulator said a link between the AstraZeneca vaccine and a rare type of blood clot, which identifies at least 62 cases of the disease, is possible. The European Medicines Agency said its safety committee will likely issue an updated recommendation next week.

Although more research is needed to examine possible links, “the most important thing to remember is the rarity of these brain clots and the powerful proven benefit of Covid vaccination,” said David Werring, a professor of clinical neurology at University College London Institute of Neurology.